Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Study of Bevacizumab in Combination With Capecitabine as First-line Treatment in Elderly Patients With Metastatic Breast Cancer

NCT01195298 is registered in ClinicalTrials.gov with South Eastern European Research Oncology Group as lead sponsor.

NCT NCT01195298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01195298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Study of Bevacizumab in Combination With Capecitabine as First-line Treatment in Elderly Patients With Metastatic Breast Cancer
Lead sponsor
South Eastern European Research Oncology Group
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2010
Completion date
Not reported
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastasis